OpenVSafe by OpenVAERS
Search V-safe

Y2V-43547-45287

3 vaccinations 4 coded responses 9 check-ins 4 free-text entries 2 call cases
Sex
Female
Age at first dose
66+
ZIP prefix
563 / MN
Registered
2021-03-12
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-27
    Dose 1 — Pfizer-BioNTech
  2. 2021-02-17
    Dose 2 — Pfizer-BioNTech
  3. 2021-03-12
    Registered in v-safe
  4. 2021-03-12
    Survey response — day 21, dose 2
    MedDRA: Dyspnoea, Dyspnoea exertional, Fatigue, Heart rate increased, Pain, Painful respiration, Red blood cell sedimentation rate increased, White blood cell count increased — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: Fast heart rate, difficulty and pain taking a deep breath, feel like I cant get a breath if moving around, elevated WBC, ESR 49, achy, extremely fatigued
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-03-12
    Report sent to call center — day 21, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  6. 2021-03-17
    Health check-in — day 28, dose 2
    Feeling: Fair
    Adult check-in
  7. 2021-03-24
    Survey response — day 35, dose 2
    MedDRA: Arrhythmia, Dyspnoea, Fatigue, Office visit, Tachycardia — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    Free text: Symptoms: Arrythmyia, tachycardia, difficulty breathing, very fatigued · Healthcare visit (other): Cardiologist, electro cardio version
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-03-24
    Report sent to call center — day 35, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  9. 2021-03-31
    Health check-in — day 42, dose 2
    Feeling: Fair
    Adult check-in
  10. 2021-05-21
    Survey response — 3 months, dose 2
    MedDRA: Chest pain, Heart rate increased, Hypoacusis, Pain — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Loss of some hearing, increased heart rate, some dull pain in the chest with a deep breath.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-08-18
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-12-06
    Call successful
    Reported to VAERS voluntarily prior to GDIT contact
  13. 2021-12-13
    Dose 3 — Janssen/Johnson & Johnson
  14. 2022-02-17
    Health check-in — 12 months, dose 2
    Feeling: Fair
    Adult check-in
  15. 2022-03-14
    Survey response — 3 months, dose 3
    MedDRA: Arthralgia, Chest pain, Heart rate increased, Neck pain, Painful respiration, Palpitations, Pericarditis, Pleurisy — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Pleurisy, pericarditis, palpitations, faster heart rate, pain in shoulder, neck and chest when breathing
    MedDRA releases: 2024-11 · check-in free text available
  16. 2022-12-13
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-27Pfizer-BioNTech
22021-02-17Pfizer-BioNTech
32021-12-13Janssen/Johnson & Johnson No

Call center

ReportedOutcomeVAERS-related outcome
2021-03-12 Successful Reported to VAERS voluntarily prior to GDIT contact
2021-03-24 Successful
2021-12-06
Reported to VAERS voluntarily prior to GDIT contact

Free text

Release 5 — day 21, dose 2

2021-03-12

Symptoms: Fast heart rate, difficulty and pain taking a deep breath, feel like I cant get a breath if moving around, elevated WBC, ESR 49, achy, extremely fatigued

Release 6 — day 35, dose 2

2021-03-24

Symptoms: Arrythmyia, tachycardia, difficulty breathing, very fatigued
Healthcare visit (other): Cardiologist, electro cardio version

Release 8 — 3 months, dose 2

2021-05-21

Symptoms: Loss of some hearing, increased heart rate, some dull pain in the chest with a deep breath.

Release 11 — 3 months, dose 3

2022-03-14

Symptoms: Pleurisy, pericarditis, palpitations, faster heart rate, pain in shoulder, neck and chest when breathing

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit ✓ ✓ ✓
SDArrhythmia ✓ ✓ ✓
SDArthralgia · · ✓
SDChest pain ✓ ✓ ✓
SDDyspnoea ✓ ✓ ✓
SDDyspnoea exertional ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDHeart rate increased ✓ ✓ ✓
SDHypoacusis ✓ ✓ ✓
SDNeck pain · · ✓
SDPain ✓ ✓ ✓
SDPainful respiration ✓ ✓ ✓
SDPalpitations · · ✓
SDPericarditis · · ✓
SDPleurisy · · ✓
SDRed blood cell sedimentation rate increased ✓ ✓ ✓
SDTachycardia ✓ ✓ ✓
SDWhite blood cell count increased ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release